5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Procter & Gamble Health Ltd.

•
pghealthindia.comBSE: 500126NSE: PGHL
Market Cap₹ 9,392 Cr.
Current Price
High / Low₹ 6,975 / 4,707
Stock P/E26.3
Book Value₹ 371
Price to Book15.33
Dividend Yield3.62 %
ROCE84.9 %
ROE62.2 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Latest quarter profit grew 45.3% YoY, showing strong momentum
  • Working capital cycle has improved - days down from 110 to 70
  • Offers a healthy dividend yield of 3.6%
  • Company converts assets efficiently - asset turnover of 2.0x

CONS

  • Stock is trading at 15.3x its book value
  • Dividend payout exceeds earnings (104.1%) - may be unsustainable

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1899.0037.67455633.710.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9100.0082.59241576.410.33902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4850.0084.58184478.410.78566.003.284921.0057.3219.2733.81
4.CIPLA1385.0033.19111888.390.94785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1121.0024.78111820.180.09990.20-34.908017.0023.9721.3924.54
6.LAURUSLABS1840.0090.9399417.450.11362.07123.942026.3129.1018.2031.50
7.LUPIN2111.0017.4696528.820.851416.9816.018276.8934.2828.8629.59
8.DRREDDY1154.0029.8996322.060.69435.60-69.108099.80-5.2113.7510.63
9.MANKIND2328.5547.0996179.610.04574.0929.124030.5912.8913.2426.30
10.AUROPHARMA1653.3025.6295127.230.241032.0325.229150.3517.4412.7620.54
11.GLENMARK2427.0038.1068495.930.10482.83927.884018.4831.3520.3520.03
12.PGHL5657.9026.329391.763.6296.1545.29363.717.3784.8627.38
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
301305310252284313310311339325374370364
256216208185236199186230248205263235270
Operating Profit45891026748114123819012011013693
OPM %15.05%29.08%32.79%26.71%17.00%36.39%39.85%26.02%26.67%37.02%29.55%36.60%25.69%
5652-183434544-28
Interest0000000000000
Depreciation6677766556666
Profit before Tax448810063231111227989119109133129
Tax %32.43%25.53%27.73%25.77%26.50%26.10%25.30%22.09%25.48%25.61%28.70%28.98%25.53%
Net Profit30667247178291616689789596
17.9639.5043.4228.0510.1149.6054.7636.8639.8753.3446.7456.9957.92

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025Mar 2026TTM
9341,4081,433
616955973
Operating Profit318453460
OPM %34.08%32.17%32.09%
1021-15
Interest011
Depreciation172424
Profit before Tax312450490
Tax %24.78%27.33%27.19%
Net Profit234327357
EPS141.21196.93—
Dividend Payout %88.52%104.10%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

STOCK PRICE CAGR

10 Years:
23%
5 Years:
1%
3 Years:
4%
1 Year:
-12%

RETURN ON EQUITY

10 Years:
—
5 Years:
—
3 Years:
—
Last Year:
62%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Aug 27

₹ 4.50

Rs.45.0000 per share(450%)Final Dividend

2026

Feb 12

₹ 5

Rs.50.0000 per share(500%)Special Dividend

2026

Feb 12

₹ 11

2025

Feb 21

₹ 8

Interim Dividend

2024

Nov 28

₹ 6

Rs.60.0000 per share(600%)Final Dividend

2024

Feb 14

₹ 15

Interim Dividend

2024

Feb 14

₹ 5

2023

Nov 23

₹ 5

Rs.50.0000 per share(500%)Final Dividend & A.G.M.

2023

Nov 13

₹ 5

Rs.50.0000 per share(500%)Final Dividend

2023

Feb 13

₹ 4.50

Interim Dividend

2022

Nov 15

₹ 1.15

Rs.11.5000 per share(115%)Final Dividend

2022

May 12

₹ 4.10

Interim Dividend

2021

Nov 2

₹ 4

Rs.130.0000 per share(1300%)Final Dividend

2021

Nov 2

₹ 9

08/12/2021 Equity Rs.90.0000 per share(900%)Special Dividend & Rs.40.0000 per share(400%)Final Dividend

2018

May 21

₹ 1.50

Rs.15.0000 per share(150%)Dividend

2017

May 25

₹ 1.10

Rs.11.0000 per share(110%)Dividend & A.G.M.

2016

Apr 22

₹ 0.75

Rs.7.5000 per share(75%)Dividend

2020

Sep 28

₹ 18.80

26/12/2020 Equity Rs.188.0000 per share(1880%)Special Dividend & Rs.42.0000 per share(420%)Final Dividend

2020

Sep 28

₹ 4.20

26/12/2020 Equity Rs.188.0000 per share(1880%)Special Dividend & Rs.42.0000 per share(420%)Final Dividend

2025

May 29

₹ 4.50

Rs.45.0000 per share(450%)Final Dividend

2026

Jul 17

₹ 4.50

Rs.45.0000 per share(450%)Final Dividend

Mar 2025Mar 2026
Equity Capital1717
515503
67
Trade Payables172192
5092
Total Liabilities759811
112100
Capital Work in Progress1114
109137
145164
Cash & Bank189185
193211
Total Assets759811

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025Mar 2026
169338
Cash from Investing101
Cash from Financing-235-344
-56-5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025Mar 2026
PER SHARE
EPS (₹)141.21196.93
Book Value (₹)320.52312.92
Dividend per Share (₹)125.00205.00
Cash EPS (₹)151.27211.14
PROFITABILITY
Operating Margin %30.94%28.90%
Net Margin %22.78%20.86%
ROE %44.15%62.18%
ROCE %58.05%84.86%
30.85%41.65%
EFFICIENCY
Debtor Days4136
Inventory Days3929
Payable Days235182
-156-117
FINANCIAL HEALTH
Debt to Equity (x)0.00x0.00x
Interest Coverage (x)725.70x818.93x
2.44x2.18x
GROWTH
Revenue Growth %-18.86%50.72%
Operating Profit Growth %2.21%44.19%
Net Profit Growth %16.63%39.46%
16.63%39.46%
VALUATION
P/E (x)36.42x24.36x
P/B (x)16.04x15.33x
Dividend Yield %2.43%4.27%
25.39x16.41x

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
51.8251.8251.8251.8251.8251.8251.8251.82
6.617.016.866.997.246.976.206.33
14.8414.7114.2114.1513.9013.8413.6712.44
Government0.000.000.000.000.000.000.000.00
26.7426.4627.1127.0327.0427.3728.3129.42

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Updates

2026-09-04 - Procter & Gamble Health Limited has informed the Exchange regarding 'This is in reference to our letter dated May 26, 2026, regarding re-appointment of Mr. S.Madhavan as Independent Director of the Company, for a period of five years, with effect fromNovember 15, 2026, subject to the approval of the shareholders of the Company. We are pleasedto inform you that the re-appointment of Mr. S. Madhavan as Independent Director of theCompany has been approved by the shareholders of the Company at its 59th Annual GeneralMeeting ( AGM ) held on September 3, 2026.'.

2026-09-04
Shareholders meeting

2026-09-04 - Procter & Gamble Health Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 03, 2026. Further, the company has informed the Exchange regarding voting results.

2026-09-03
Shareholders meeting

2026-09-03 - Procter & Gamble Health Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 03, 2026

2026-09-03
Shareholders meeting

2026-09-03 - Procter & Gamble Health Limited has informed the Exchange about Shareholders meeting

2026-08-12
Shareholders meeting

2026-08-12 - Procter & Gamble Health Limited has informed the Exchange about Shareholders meeting

2026-08-10
Revised Record date

2026-08-10 - Procter & Gamble Health Limited had intimated the 21-Aug-2026 as the record date. The Company has now informed the Exchange that the Record date has been revised to 27-Aug-2026 for the purpose of DI.

2026-08-06
Press Release

2026-08-06 - Procter & Gamble Health Limited has informed the Exchange regarding a press release dated August 06, 2026, titled "Press Release on the unaudited Financial Results for the quarter ended June 30, 2026".

2026-08-06
Outcome of Board Meeting

2026-08-06 - Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the quarter ended June 30, 2026.

2026-07-15
General Updates

2026-07-15 - Procter & Gamble Health Limited has informed the Exchange regarding revision in date of Company s Annual General Meeting for the Financial Year 2025-26 and Record date for the purpose of AGM and Final Dividend

News

Recent coverage and analyst commentary for PGHL

Loading news…

🤖

AI Stock Analyst

Procter & Gamble Health Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login